ADK-957АДК-957
An experimental adamantane chlorophenoxyacetamide. A 2019 chemistry paper identifies the compound and cites earlier cold-exposure research without reporting the original results.
What the studies found
Laboratory analysis · 2019
Synthesis of New Camphane-Type Amides: Potential Synthetic Adaptogenes
Findings for this preparation
ADK-957 appears as a background chlorophenoxyacetamide lead in this chemistry paper. Its cited cold-protection claim requires the original pharmacology report; this is not a new efficacy experiment on ADK-957.
Study notes · methods, sources and limitations
Participants or model Chemical synthesis and characterization; background pharmacology citations
Important limitations
- Chemical characterization and a potential-adaptogen label do not demonstrate pharmacological efficacy. ADK-957’s original cold-exposure experiment and detailed safety data remain acquisition targets.
Russian Journal of General Chemistry. 89(3):399–404 · Publication record
About ADK-957
Research background
The 2019 chemistry report cites earlier work on cold exposure. It provides chemical context for ADK-957 but gives no group results for the historical experiment.
- Compound class
- Experimental adamantane / analogue
- Research collection
- Actoprotection & occupational pharmacology · editorial grouping
- Institutions in linked studies
- See individual study records
- Source review
- Review dates and the material assessed are listed with each publication below.
Understanding the evidence
Human research
Human efficacy results unavailable
Study methods
Source-specific animal, chemistry, patent or dissertation evidence
Independent replication
Independent replication not established; translations are not separate experiments
Source access
Access and review depth appear with each linked record
Safety evidence
Human safety and interactions not established; animal activity is not a safe-use recommendation
Open a topic for the evidence assessment.
Findings by study
Laboratory analysis · 2019
Synthesis of New Camphane-Type Amides: Potential Synthetic Adaptogenes
ADK-957 appears as a background chlorophenoxyacetamide lead in this chemistry paper. Its cited cold-protection claim requires the original pharmacology report; this is not a new efficacy experiment on ADK-957.
Study notes and original source
Synthesis of New Camphane-Type Amides: Potential Synthetic Adaptogenes
I. A. Novakov, R. V. Brunilin, G. M. Butov, A. A. Vernigora, M. B. Navrotskii, A. S. Yablokov, S. N. Voloboev · Russian Journal of General Chemistry. 89(3):399–404
The study reports synthesis and characterization of camphane analogues and links their design to Chlodantane and related adamantanes. ADK-957 appears as a chlorophenoxyacetamide background lead; cited cold-protection activity is not a new clinical result in this chemistry paper.
- Population / setting
- Chemical synthesis and characterization; background pharmacology citations
- Source reviewed
- Author-uploaded paper’s accessible chemistry/background passages checked; earlier pharmacology not independently recovered.
Study limitations
- Chemical characterization and a potential-adaptogen label do not demonstrate pharmacological efficacy.
- ADK-957’s original cold-exposure experiment and detailed safety data remain acquisition targets.
Reviewed 2026-10-03.
Related compound research
Follow shared publications or research classes. These links do not establish equivalent effects between compounds.
Research collection curated by @PepMariner · editorial standards. Send a source correction ↗
Browse bibliography & PDFs ↗